We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
HSPE1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • HSPE1
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

HSPE1 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 457.88
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 579.9
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 2483.0
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 2003.8
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 1476.0
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 1421.3
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 1320.2
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 1314.6
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 1268.8
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 1237.3
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 1210.7
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 1137.6
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 1131.1
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 1073.3
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 1060.5
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 1037.4
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 1035.7
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 1021.0
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 1019.3
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 997.5
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 995.7
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 981.3
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 979.2
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 977.4
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 974.8
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 963.6
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 959.6
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 949.8
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 945.9
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 943.7
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 942.9
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 941.4
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 929.2
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 923.0
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 922.3
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 919.5
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 902.9
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 902.7
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 898.2
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 890.0
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 881.9
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 880.0
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 877.0
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 870.5
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 868.2
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 861.4
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 861.4
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 861.3
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 859.3
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 859.3
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 858.8
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 857.4
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 856.0
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 855.2
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 851.9
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 842.7
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 837.6
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 834.0
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 830.8
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 827.4
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 823.0
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 822.8
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 819.8
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 812.1
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 811.9
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 811.1
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 802.2
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 801.8
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 796.1
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 792.9
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 782.3
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 778.2
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 777.0
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 773.7
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 773.6
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 746.0
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 746.0
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 742.9
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 742.4
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 741.0
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 738.8
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 737.3
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 736.8
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 735.5
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 733.7
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 723.3
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 721.7
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 720.9
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 720.5
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 718.1
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 716.9
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 713.3
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 709.8
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 707.1
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 706.6
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 706.3
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 701.3
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 701.2
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 700.2
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 696.5
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 693.5
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 692.4
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 692.3
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 691.0
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 690.7
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 685.4
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 681.7
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 681.5
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 680.5
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 678.1
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 676.7
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 676.5
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 673.3
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 669.4
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 667.8
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 661.8
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 659.5
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 659.4
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 658.1
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 654.0
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 644.7
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 642.7
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 640.3
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 635.5
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 633.7
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 630.5
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 630.2
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 626.0
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 625.4
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 624.3
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 624.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 621.6
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 619.9
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 619.6
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 619.4
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 616.4
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 615.5
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 614.8
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 614.0
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 611.5
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 603.3
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 602.2
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 602.0
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 602.0
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 600.2
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 594.6
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 585.6
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 583.1
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 582.0
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 581.5
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 577.2
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 576.3
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 575.5
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 573.8
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 573.8
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 573.7
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 572.7
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 568.9
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 567.8
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 566.1
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 564.8
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 563.0
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 562.0
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 561.4
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 557.7
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 555.1
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 551.6
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 551.3
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 549.9
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 549.8
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 548.2
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 542.6
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 539.5
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 539.1
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 538.9
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 537.8
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 535.4
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 535.1
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 534.6
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 533.5
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 527.6
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 527.5
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 527.3
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 523.8
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 521.2
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 517.6
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 516.4
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 516.0
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 514.6
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 514.2
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 514.1
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 511.4
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 510.8
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 508.8
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 508.7
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 507.1
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 506.1
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 503.5
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 501.2
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 499.9
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 497.3
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 495.1
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 494.6
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 493.1
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 493.1
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 492.5
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 491.5
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 489.4
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 489.3
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 488.9
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 488.8
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 487.7
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 487.1
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 484.8
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 482.4
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 481.9
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 481.7
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 475.5
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 474.2
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 472.8
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 471.7
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 470.8
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 470.7
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 470.6
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 468.2
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 467.4
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 466.1
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 464.8
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 463.7
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 463.3
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 462.0
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 461.6
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 461.3
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 460.9
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 457.9
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 455.3
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 454.2
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 453.3
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 452.3
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 451.6
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 448.9
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 447.1
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 446.7
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 445.2
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 444.0
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 443.8
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 443.0
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 437.2
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 433.7
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 433.3
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 429.5
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 428.8
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 428.2
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 428.1
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 426.5
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 426.3
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 424.3
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 422.4
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 421.8
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 420.7
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 418.2
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 416.5
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 416.1
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 416.0
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 414.7
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 413.3
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 413.3
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 411.0
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 410.0
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 409.6
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 408.4
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 406.9
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 404.5
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 402.7
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 401.8
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 399.5
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 398.5
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 397.7
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 396.1
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 394.6
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 390.8
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 390.7
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 389.3
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 388.8
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 385.8
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 382.8
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 380.9
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 377.8
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 377.4
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 377.0
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 376.3
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 375.7
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 374.6
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 373.6
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 372.5
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 368.9
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 365.9
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 362.9
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 360.3
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 359.2
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 356.5
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 356.3
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 353.9
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 350.6
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 349.9
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 348.5
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 339.1
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 338.2
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 338.0
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 336.9
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 335.3
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 327.4
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 327.2
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 326.6
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 322.8
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 321.3
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 319.4
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 319.1
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 318.1
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 317.2
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 311.3
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 310.1
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 307.9
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 307.2
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 305.9
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 303.1
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 300.9
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 300.6
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 300.5
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 299.8
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 299.0
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 298.1
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 296.5
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 296.3
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 292.6
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 291.8
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 284.6
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 283.5
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 273.8
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 271.0
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 270.2
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 267.9
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 267.3
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 265.6
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 264.4
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 261.0
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 257.8
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 256.6
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 254.4
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 254.1
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 248.8
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 243.8
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 242.3
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 242.0
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 241.4
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 240.5
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 232.5
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 228.8
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 227.1
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 221.7
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 212.3
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 207.0
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 181.2
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 159.6
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

HSPE1 is potential prognostic, high expression is unfavorable in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 407.24
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 424.0
Number of samples 231
Samples
Sample Description pTPM
DO50815 62 years, male, NA, stage:3, alive, 150 days 1898.2
DO45145 78 years, male, NA, stage:3, dead, 60 days 1213.9
DO23519 65 years, male, NA, stage:3, alive, 630 days 1188.9
DO50857 72 years, male, NA, stage:2, alive, 210 days 1112.6
DO48733 72 years, male, NA, stage:2, alive, 600 days 977.0
DO23546 63 years, male, NA, stage:2, alive, 1050 days 911.5
DO48737 52 years, male, NA, stage:1, alive, 720 days 903.0
DO23525 71 years, male, NA, stage:4, alive, 1050 days 853.2
DO23521 63 years, male, NA, stage:3, alive, 1110 days 781.6
DO48723 73 years, male, NA, stage:1, alive, 600 days 777.0
DO23551 73 years, male, NA, stage:3, dead, 150 days 753.7
DO45297 61 years, female, NA, stage:4, dead, 1260 days 747.1
DO23528 45 years, female, NA, stage:2, alive, 1020 days 743.8
DO45193 68 years, female, NA, stage:4, dead, 120 days 740.4
DO48741 64 years, male, NA, stage:3, alive, 240 days 709.2
DO45123 78 years, female, NA, stage:2, dead, 570 days 707.9
DO50791 79 years, female, NA, stage:1, dead, 480 days 705.7
DO45127 73 years, male, NA, stage:3, dead, 420 days 690.6
DO45091 56 years, male, NA, stage:2, dead, 1320 days 675.5
DO50778 60 years, male, NA, stage:4, alive, 630 days 657.3
DO45267 73 years, male, NA, stage:3, dead, 570 days 648.5
DO45283 60 years, male, NA, stage:3, alive, 510 days 647.1
DO48672 81 years, male, NA, stage:2, alive, 450 days 647.1
DO45117 73 years, female, NA, stage:2, dead, 1110 days 637.7
DO48720 62 years, female, NA, stage:2, alive, 570 days 633.1
DO50825 70 years, male, NA, stage:2, alive, 390 days 630.5
DO23509 60 years, male, NA, stage:3, dead, 780 days 613.7
DO23526 66 years, male, NA, stage:3, alive, 1050 days 610.0
DO23510 80 years, female, NA, stage:2, alive, 870 days 609.8
DO48728 74 years, female, NA, stage:2, alive, 150 days 607.7
DO45273 62 years, male, NA, stage:2, alive, 480 days 607.5
DO45183 72 years, female, NA, stage:2, dead, 570 days 606.8
DO23541 65 years, male, NA, stage:2, alive, 930 days 606.7
DO45099 46 years, male, NA, stage:3, alive, 1590 days 606.0
DO45143 69 years, male, NA, stage:3, alive, 1290 days 604.1
DO23513 76 years, male, NA, stage:3, alive, 1200 days 597.6
DO23547 74 years, male, NA, stage:1, alive, 1020 days 589.5
DO23533 61 years, male, NA, stage:2, alive, 900 days 579.0
DO50774 68 years, female, NA, stage:2, alive, 720 days 571.1
DO45093 71 years, male, NA, stage:2, dead, 720 days 568.2
DO45305 66 years, male, NA, stage:4, alive, 300 days 567.8
DO50785 37 years, male, NA, stage:4, dead, 90 days 563.2
DO45261 74 years, male, NA, stage:3, alive, 990 days 555.9
DO45241 49 years, male, NA, stage:1, alive, 1080 days 536.3
DO50802 49 years, male, NA, stage:2, alive, 930 days 532.0
DO48730 73 years, female, NA, stage:2, alive, 630 days 529.4
DO45243 74 years, female, NA, stage:3, alive, 930 days 529.2
DO45119 74 years, male, NA, stage:3, dead, 510 days 526.6
DO50809 56 years, male, NA, stage:3, dead, 720 days 523.0
DO50859 77 years, male, NA, stage:2, alive, 180 days 522.0
DO50799 66 years, female, NA, stage:2, alive, 540 days 521.8
DO48700 78 years, female, NA, stage:2, alive, 810 days 520.4
DO45275 65 years, male, NA, stage:3, dead, 10 days 520.2
DO45245 75 years, female, NA, stage:2, dead, 240 days 516.6
DO50805 72 years, male, NA, stage:2, alive, 690 days 513.4
DO50789 73 years, female, NA, stage:2, alive, 570 days 512.7
DO45257 46 years, male, NA, stage:3, alive, 810 days 511.1
DO48759 73 years, male, NA, stage:3, alive, 720 days 509.6
DO45217 69 years, female, NA, stage:3, dead, 270 days 507.0
DO45171 56 years, male, NA, stage:3, alive, 600 days 498.5
DO45139 63 years, male, NA, stage:3, alive, 1320 days 494.5
DO50820 77 years, female, NA, stage:3, alive, 510 days 494.3
DO48751 68 years, male, NA, stage:2, dead, 480 days 494.1
DO48679 72 years, male, NA, stage:2, alive, 1200 days 492.7
DO50832 73 years, male, NA, stage:3, alive, 90 days 487.0
DO45303 62 years, female, NA, stage:3, alive, 990 days 481.5
DO45269 59 years, male, NA, stage:3, alive, 750 days 480.5
DO23534 60 years, male, NA, stage:2, alive, 840 days 472.4
DO45299 70 years, female, NA, stage:1, alive, 1440 days 472.1
DO23539 77 years, male, NA, stage:1, alive, 1110 days 470.0
DO48704 68 years, female, NA, stage:3, alive, 750 days 469.6
DO45131 53 years, male, NA, stage:4, dead, 360 days 463.2
DO45253 50 years, male, NA, stage:2, alive, 870 days 461.3
DO50808 68 years, male, NA, stage:2, alive, 570 days 459.2
DO50844 75 years, male, NA, stage:4, alive, 300 days 457.1
DO45307 54 years, female, NA, stage:4, dead, 240 days 455.1
DO45213 58 years, male, NA, stage:1, alive, 1200 days 454.7
DO23549 74 years, male, NA, stage:3, alive, 990 days 454.5
DO45137 38 years, male, NA, stage:1, alive, 1320 days 451.9
DO45289 78 years, female, NA, stage:3, alive, 360 days 450.1
DO23543 63 years, male, NA, stage:2, alive, 1020 days 449.3
DO45255 81 years, male, NA, stage:3, alive, 720 days 445.4
DO50806 70 years, male, NA, stage:4, alive, 540 days 442.2
DO50829 78 years, male, NA, stage:3, alive, 570 days 441.6
DO227643 79 years, male, NA, stage:2, alive, 1260 days 436.9
DO45141 73 years, male, NA, stage:2, alive, 1320 days 428.2
DO50798 77 years, male, NA, stage:3, dead, 30 days 425.0
DO48697 64 years, female, NA, stage:2, dead, 810 days 424.2
DO45201 49 years, male, NA, stage:1, alive, 900 days 423.0
DO50840 49 years, male, NA, stage:2, alive, 330 days 423.0
DO23545 67 years, male, NA, stage:2, dead, 570 days 422.2
DO45205 67 years, female, NA, stage:2, dead, 90 days 421.5
DO45092 62 years, male, NA, stage:4, dead, 1200 days 420.9
DO45235 68 years, female, NA, stage:1, alive, 900 days 419.5
DO45185 89 years, male, NA, stage:2, alive, 600 days 418.5
DO23512 60 years, male, NA, stage:1, alive, 1260 days 417.5
DO45133 64 years, male, NA, stage:3, dead, 660 days 416.8
DO45203 71 years, female, NA, stage:2, alive, 1170 days 416.0
DO45161 74 years, male, NA, stage:2, dead, 540 days 416.0
DO23544 67 years, male, NA, stage:2, alive, 960 days 415.0
DO45163 76 years, male, NA, stage:2, alive, 960 days 408.0
DO48682 72 years, female, NA, stage:3, dead, 120 days 407.8
DO45121 61 years, male, NA, stage:3, alive, 1530 days 406.7
DO45135 77 years, male, NA, stage:1, alive, 1410 days 406.3
DO45165 75 years, male, NA, stage:2, alive, 690 days 405.1
DO48732 73 years, male, NA, stage:3, alive, 630 days 404.8
DO23508 79 years, female, NA, stage:2, alive, 390 days 403.0
DO45105 61 years, male, NA, stage:1, alive, 1680 days 402.2
DO45239 42 years, male, NA, stage:2, alive, 870 days 397.2
DO50811 62 years, male, NA, stage:1, alive, 450 days 397.1
DO45221 75 years, female, NA, stage:4, dead, 390 days 396.9
DO50803 62 years, female, NA, stage:1, alive, 540 days 394.3
DO23514 64 years, male, NA, stage:2, alive, 1290 days 393.9
DO50816 63 years, male, NA, stage:2, alive, 390 days 392.3
DO45263 67 years, male, NA, stage:3, dead, 270 days 389.9
DO23542 66 years, male, NA, stage:3, alive, 960 days 388.1
DO48761 55 years, male, NA, stage:2, alive, 870 days 386.3
DO45095 66 years, male, NA, stage:2, alive, 1620 days 382.2
DO45281 83 years, male, NA, stage:4, alive, 750 days 381.9
DO48725 66 years, male, NA, stage:1, alive, 780 days 380.8
DO45301 56 years, male, NA, stage:2, dead, 1440 days 380.4
DO45101 63 years, male, NA, stage:2, alive, 1680 days 379.5
DO45129 61 years, male, NA, stage:3, alive, 1470 days 379.3
DO45211 76 years, male, NA, stage:3, alive, 240 days 378.5
DO23518 67 years, male, NA, stage:2, alive, 1320 days 377.7
DO45115 81 years, male, NA, stage:2, alive, 840 days 375.8
DO45219 78 years, male, NA, stage:2, alive, 1080 days 374.6
DO45197 51 years, male, NA, stage:2, alive, 1170 days 373.6
DO45103 47 years, male, NA, stage:3, alive, 450 days 369.1
DO23524 71 years, female, NA, stage:2, alive, 1050 days 367.7
DO45159 65 years, male, NA, stage:3, alive, 1470 days 367.5
DO227801 77 years, female, NA, stage:1, alive, 660 days 367.4
DO50807 67 years, male, NA, stage:1, alive, 540 days 365.0
DO48721 58 years, female, NA, stage:1, alive, 900 days 364.5
DO45096 69 years, male, NA, stage:2, dead, 1290 days 364.2
DO48695 77 years, male, NA, stage:2, alive, 720 days 363.6
DO48757 68 years, female, NA, stage:3, alive, 480 days 361.8
DO45265 73 years, male, NA, stage:3, alive, 1020 days 360.8
DO23535 67 years, male, NA, stage:1, alive, 960 days 358.5
DO50822 66 years, male, NA, stage:2, alive, 510 days 357.0
DO45169 74 years, male, NA, stage:3, alive, 1350 days 356.2
DO50819 72 years, female, NA, stage:2, alive, 510 days 355.9
DO45153 77 years, female, NA, stage:2, alive, 1380 days 355.4
DO45195 62 years, male, NA, stage:1, alive, 390 days 348.9
DO45175 74 years, male, NA, stage:2, alive, 1140 days 344.8
DO23552 80 years, female, NA, stage:1, alive, 810 days 343.7
DO48716 71 years, male, NA, stage:2, alive, 720 days 341.4
DO45223 67 years, male, NA, stage:4, alive, 1020 days 340.3
DO45191 61 years, female, NA, stage:2, alive, 1200 days 337.8
DO48719 80 years, male, NA, stage:2, alive, 690 days 337.5
DO45259 65 years, male, NA, stage:3, alive, 330 days 333.1
DO23515 71 years, male, NA, stage:2, alive, 1230 days 333.1
DO48693 71 years, male, NA, stage:2, alive, 900 days 324.8
DO50850 74 years, male, NA, stage:3, alive, 720 days 321.7
DO50845 72 years, male, NA, stage:3, alive, 210 days 320.8
DO45227 57 years, female, NA, stage:2, alive, 1020 days 320.8
DO45187 32 years, female, NA, stage:1, alive, 1260 days 311.3
DO45189 85 years, female, NA, stage:2, alive, 1200 days 309.8
DO23536 56 years, male, NA, stage:2, alive, 930 days 309.1
DO23529 72 years, male, NA, stage:4, alive, 930 days 308.3
DO45277 64 years, male, NA, stage:3, alive, 600 days 308.1
DO45167 67 years, male, NA, stage:2, dead, 1440 days 307.6
DO48717 54 years, male, NA, stage:4, dead, 180 days 307.3
DO23550 69 years, male, NA, stage:1, alive, 990 days 305.4
DO45107 63 years, female, NA, stage:2, alive, 1710 days 304.9
DO23537 79 years, male, NA, stage:2, dead, 900 days 303.1
DO45225 69 years, male, NA, stage:1, alive, 1050 days 302.4
DO23548 78 years, female, NA, stage:1, alive, 840 days 300.2
DO45179 78 years, female, NA, stage:2, alive, 600 days 298.4
DO45199 86 years, female, NA, stage:2, alive, 1350 days 297.7
DO23516 69 years, male, NA, stage:3, dead, 20 days 296.0
DO50813 56 years, male, NA, stage:2, alive, 420 days 293.6
DO50817 75 years, male, NA, stage:2, alive, 390 days 289.9
DO50814 83 years, male, NA, stage:3, alive, 420 days 288.8
DO45155 69 years, male, NA, stage:2, alive, 2160 days 285.1
DO45247 31 years, female, NA, stage:2, alive, 210 days 282.3
DO50776 75 years, male, NA, stage:1, alive, 690 days 281.8
DO45285 59 years, male, NA, stage:3, alive, 480 days 281.3
DO45287 74 years, male, NA, stage:1, alive, 390 days 280.7
DO48706 72 years, male, NA, stage:2, alive, 870 days 279.2
DO23511 83 years, female, NA, stage:3, dead, 180 days 279.1
DO45173 63 years, male, NA, stage:3, alive, 1170 days 277.3
DO48736 76 years, female, NA, stage:1, alive, 600 days 273.9
DO45279 67 years, male, NA, stage:3, alive, 1290 days 272.0
DO45215 65 years, male, NA, stage:2, alive, 1170 days 270.0
DO50855 47 years, male, NA, stage:2, alive, 570 days 266.4
DO45157 62 years, male, NA, stage:2, alive, 1980 days 265.8
DO48681 57 years, male, NA, stage:2, alive, 900 days 264.6
DO45125 58 years, male, NA, stage:3, alive, 1680 days 264.4
DO45237 58 years, male, NA, stage:2, alive, 900 days 263.6
DO50787 63 years, male, NA, stage:3, alive, 480 days 263.4
DO48701 78 years, male, NA, stage:2, alive, 780 days 257.9
DO48674 80 years, male, NA, stage:2, alive, 1260 days 257.4
DO50800 74 years, male, NA, stage:2, alive, 510 days 250.3
DO45209 70 years, male, NA, stage:4, alive, 1350 days 249.7
DO48743 69 years, female, NA, stage:2, alive, 570 days 248.8
DO48715 58 years, female, NA, stage:2, dead, 690 days 248.3
DO48712 50 years, male, NA, stage:2, alive, 810 days 247.6
DO50783 62 years, male, NA, stage:3, alive, 480 days 246.9
DO50839 47 years, female, NA, stage:3, alive, 330 days 246.7
DO45229 74 years, male, NA, stage:1, alive, 990 days 243.3
DO23540 73 years, male, NA, stage:1, alive, 750 days 243.3
DO45251 57 years, female, NA, stage:2, alive, 900 days 241.1
DO23530 53 years, male, NA, stage:4, dead, 180 days 241.1
DO50793 76 years, male, NA, stage:4, alive, 540 days 240.3
DO45207 68 years, male, NA, stage:1, alive, 1050 days 237.2
DO45231 84 years, male, NA, stage:2, alive, 930 days 235.6
DO48746 76 years, male, NA, stage:3, alive, 570 days 235.0
DO45111 74 years, male, NA, stage:2, alive, 1590 days 232.0
DO23527 72 years, male, NA, stage:1, alive, 1050 days 231.8
DO45097 69 years, male, NA, stage:3, alive, 1620 days 231.6
DO48742 76 years, male, NA, stage:2, alive, 600 days 228.6
DO45109 63 years, male, NA, stage:2, alive, 1590 days 225.8
DO48747 62 years, male, NA, stage:3, alive, 540 days 223.9
DO45177 81 years, female, NA, stage:3, alive, 1260 days 219.8
DO45233 83 years, male, NA, stage:3, alive, 900 days 217.8
DO48727 81 years, female, NA, stage:2, dead, 390 days 216.3
DO48760 70 years, female, NA, stage:2, alive, 690 days 216.1
DO45181 84 years, female, NA, stage:2, alive, 1200 days 208.9
DO45113 58 years, male, NA, stage:3, alive, 1560 days 205.9
DO50804 81 years, male, NA, stage:2, alive, 720 days 205.6
DO50818 65 years, male, NA, stage:2, alive, 510 days 204.4
DO48677 58 years, male, NA, stage:3, alive, 1140 days 194.3
DO23517 62 years, male, NA, stage:2, alive, 1200 days 181.9
DO23538 67 years, male, NA, stage:2, alive, 450 days 173.8
DO23531 78 years, female, NA, stage:3, alive, 900 days 173.5
DO45249 57 years, male, NA, stage:1, alive, 630 days 164.0
DO45094 76 years, male, NA, stage:3, alive, 1650 days 160.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 149.3
DO23523 52 years, male, NA, stage:3, alive, 1080 days 141.1
DO45149 70 years, female, NA, stage:2, alive, 1260 days 122.3
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
925 Tumor 1.7
571 Tumor 1.4
743 Tumor 1.3
745 Tumor 1.1
227 Tumor 1.1
873 Tumor 1.0
127 Tumor 1.0
627 Tumor 1.0
231 Tumor 0.9
537 Tumor 0.9
695 Tumor 0.8
477 Tumor 0.8
435 Tumor 0.8
911 Tumor 0.7
487 Tumor 0.7
567 Tumor 0.7
517 Tumor 0.6
867 Tumor 0.6
937 Tumor 0.6
1045 Tumor 0.5
471 Tumor 0.5
1041 Tumor 0.5
857 Tumor 0.5
1013 Tumor 0.5
411 Tumor 0.5
963 Tumor 0.5
112 Tumor 0.5
361 Tumor 0.5
483 Tumor 0.5
1015 Tumor 0.4
698 Normal 0.4
465 Tumor 0.4
443 Tumor 0.4
1031 Tumor 0.4
823 Tumor 0.4
967 Tumor 0.4
951 Tumor 0.4
128 Normal 0.4
1043 Tumor 0.3
415 Tumor 0.3
1032 Normal 0.3
535 Tumor 0.3
635 Tumor 0.3
145 Tumor 0.3
922 Normal 0.3
1014 Normal 0.3
824 Normal 0.3
534 Normal 0.3
473 Tumor 0.3
883 Tumor 0.3
964 Normal 0.2
557 Tumor 0.2
984 Normal 0.2
1025 Tumor 0.2
641 Tumor 0.2
553 Tumor 0.2
686 Normal 0.2
393 Tumor 0.2
171 Tumor 0.2
953 Tumor 0.2
462 Normal 0.2
484 Normal 0.2
383 Tumor 0.2
431 Tumor 0.2
636 Normal 0.2
615 Tumor 0.2
715 Tumor 0.2
868 Normal 0.2
1027 Tumor 0.2
981 Tumor 0.2
546 Normal 0.2
862 Normal 0.2
1022 Normal 0.2
448 Normal 0.2
341 Tumor 0.2
356 Normal 0.2
983 Tumor 0.2
113 Tumor 0.2
723 Tumor 0.2
866 Normal 0.2
912 Normal 0.2
1046 Normal 0.2
572 Normal 0.2
697 Tumor 0.2
363 Tumor 0.2
921 Tumor 0.2
488 Normal 0.1
742 Normal 0.1
861 Tumor 0.1
1044 Normal 0.1
746 Normal 0.1
944 Normal 0.1
915 Tumor 0.1
367 Tumor 0.1
696 Normal 0.1
982 Normal 0.1
713 Tumor 0.1
786 Normal 0.1
818 Normal 0.1
882 Normal 0.1
1026 Normal 0.1
954 Normal 0.1
864 Normal 0.1
756 Normal 0.1
482 Normal 0.1
924 Normal 0.1
423 Tumor 0.1
852 Normal 0.1
665 Tumor 0.1
858 Normal 0.1
1016 Normal 0.1
135 Tumor 0.1
616 Normal 0.1
123 Tumor 0.1
741 Tumor 0.0
161 Tumor 0.0
716 Normal 0.0
663 Tumor 0.0
722 Normal 0.0
918 Normal 0.0
412 Normal 0.0
926 Normal 0.0
463 Tumor 0.0
1028 Normal 0.0
472 Normal 0.0
526 Normal 0.0
297 Tumor 0.0
514 Normal 0.0
267 Tumor 0.0
976 Normal 0.0
452 Normal 0.0
388 Normal 0.0
568 Normal 0.0
714 Normal 0.0
494 Normal 0.0
344 Normal 0.0
738 Normal 0.0
558 Normal 0.0
528 Normal 0.0
874 Normal 0.0
573 Tumor 0.0
923 Tumor 0.0
648 Normal 0.0
744 Normal 0.0
376 Normal 0.0
721 Tumor 0.0
554 Normal 0.0
968 Normal 0.0
564 Normal 0.0
328 Normal 0.0
191 Tumor 0.0
938 Normal 0.0
425 Tumor 0.0
131 Tumor -0.1
364 Normal -0.1
618 Normal -0.1
755 Tumor -0.1
142 Normal -0.1
884 Normal -0.1
394 Normal -0.1
955 Tumor -0.1
914 Normal -0.1
916 Normal -0.1
778 Normal -0.1
728 Normal -0.1
137 Tumor -0.1
221 Tumor -0.1
172 Normal -0.1
958 Normal -0.1
391 Tumor -0.1
524 Normal -0.1
563 Tumor -0.1
878 Normal -0.1
466 Normal -0.1
628 Normal -0.1
525 Tumor -0.1
228 Normal -0.1
851 Tumor -0.1
474 Normal -0.1
327 Tumor -0.1
978 Normal -0.1
913 Tumor -0.1
357 Tumor -0.1
196 Normal -0.1
433 Tumor -0.1
358 Normal -0.1
642 Normal -0.1
342 Normal -0.1
352 Normal -0.2
513 Tumor -0.2
481 Tumor -0.2
515 Tumor -0.2
421 Tumor -0.2
445 Tumor -0.2
724 Normal -0.2
186 Normal -0.2
286 Normal -0.2
416 Normal -0.2
468 Normal -0.2
392 Normal -0.2
396 Normal -0.2
212 Normal -0.2
785 Tumor -0.2
816 Normal -0.2
427 Tumor -0.2
518 Normal -0.2
284 Normal -0.2
436 Normal -0.2
538 Normal -0.2
354 Normal -0.2
1042 Normal -0.2
232 Normal -0.2
664 Normal -0.2
222 Normal -0.2
331 Tumor -0.2
332 Normal -0.2
114 Normal -0.2
966 Normal -0.2
516 Normal -0.2
414 Normal -0.3
685 Tumor -0.3
533 Tumor -0.3
965 Tumor -0.3
536 Normal -0.3
365 Tumor -0.3
223 Tumor -0.3
422 Normal -0.3
523 Tumor -0.3
461 Tumor -0.3
952 Normal -0.3
132 Normal -0.3
956 Normal -0.3
214 Normal -0.3
451 Tumor -0.3
428 Normal -0.3
271 Tumor -0.3
957 Tumor -0.3
261 Tumor -0.3
384 Normal -0.3
162 Normal -0.3
493 Tumor -0.3
385 Tumor -0.3
881 Tumor -0.3
478 Normal -0.3
362 Normal -0.3
617 Tumor -0.3
424 Normal -0.3
527 Tumor -0.3
217 Tumor -0.3
574 Normal -0.3
314 Normal -0.3
258 Normal -0.3
313 Tumor -0.3
111 Normal -0.3
977 Tumor -0.4
218 Normal -0.4
446 Normal -0.4
224 Normal -0.4
426 Normal -0.4
138 Normal -0.4
815 Tumor -0.4
447 Tumor -0.4
298 Normal -0.4
672 Normal -0.4
387 Tumor -0.4
498 Normal -0.4
148 Normal -0.4
662 Normal -0.4
124 Normal -0.4
351 Tumor -0.4
272 Normal -0.4
492 Normal -0.4
497 Tumor -0.4
368 Normal -0.4
432 Normal -0.4
727 Tumor -0.4
666 Normal -0.4
975 Tumor -0.4
1021 Tumor -0.4
187 Tumor -0.4
353 Tumor -0.4
863 Tumor -0.5
366 Normal -0.5
126 Normal -0.5
262 Normal -0.5
185 Tumor -0.5
464 Normal -0.5
386 Normal -0.5
737 Tumor -0.5
136 Normal -0.5
877 Tumor -0.5
413 Tumor -0.5
146 Normal -0.5
285 Tumor -0.5
147 Tumor -0.5
278 Normal -0.5
195 Tumor -0.5
865 Tumor -0.6
456 Normal -0.6
455 Tumor -0.6
491 Tumor -0.6
277 Tumor -0.6
647 Tumor -0.6
355 Tumor -0.6
188 Normal -0.6
813 Tumor -0.6
777 Tumor -0.7
444 Normal -0.7
434 Normal -0.7
312 Normal -0.7
671 Tumor -0.7
395 Tumor -0.7
257 Tumor -0.7
268 Normal -0.8
125 Tumor -0.8
375 Tumor -0.9
213 Tumor -0.9
814 Normal -0.9
141 Tumor -0.9
943 Tumor -0.9
661 Tumor -1.0
817 Tumor -1.0
192 Normal -1.1
283 Tumor -1.1
343 Tumor -1.2
211 Tumor -1.2
917 Tumor -1.2
311 Tumor -1.4
467 Tumor -1.4
545 Tumor -1.5
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA038755

Antibody HPA048272

Antibody CAB017366
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org